IN2012DN02463A - - Google Patents

Download PDF

Info

Publication number
IN2012DN02463A
IN2012DN02463A IN2463DEN2012A IN2012DN02463A IN 2012DN02463 A IN2012DN02463 A IN 2012DN02463A IN 2463DEN2012 A IN2463DEN2012 A IN 2463DEN2012A IN 2012DN02463 A IN2012DN02463 A IN 2012DN02463A
Authority
IN
India
Prior art keywords
present
weight management
relates
field
bifidobacterium longum
Prior art date
Application number
Other languages
English (en)
Inventor
De Bercik Elena Verdu
Premysl Bercik
Stephen Michael Collins
Degonda Gabriela Bergonzelli
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41683555&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN02463(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of IN2012DN02463A publication Critical patent/IN2012DN02463A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IN2463DEN2012 2009-09-30 2010-09-28 IN2012DN02463A (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09171866A EP2308499A1 (en) 2009-09-30 2009-09-30 Bifidobacterium longum ATCC BAA-999 (BL999) and weight control
PCT/EP2010/064348 WO2011039176A1 (en) 2009-09-30 2010-09-28 Bifidobacterium longum atcc baa-999 (bl999) and weight control

Publications (1)

Publication Number Publication Date
IN2012DN02463A true IN2012DN02463A (xx) 2015-05-22

Family

ID=41683555

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2463DEN2012 IN2012DN02463A (xx) 2009-09-30 2010-09-28

Country Status (14)

Country Link
US (1) US20120244125A1 (xx)
EP (2) EP2308499A1 (xx)
JP (1) JP5911424B2 (xx)
CN (1) CN102665737A (xx)
AR (1) AR078485A1 (xx)
AU (1) AU2010303020B2 (xx)
BR (1) BR112012007109A2 (xx)
CA (1) CA2775976A1 (xx)
CL (1) CL2012000809A1 (xx)
IN (1) IN2012DN02463A (xx)
MX (1) MX2012003612A (xx)
RU (1) RU2567660C2 (xx)
SG (1) SG10201406169VA (xx)
WO (1) WO2011039176A1 (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5615285B2 (ja) * 2010-03-18 2014-10-29 森永乳業株式会社 貧血の予防又は治療用組成物
EP2452575A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Array of age-tailored nutritional formula with probiotics
FI20116008A0 (fi) 2011-10-12 2011-10-12 Maeyrae Maekinen Annika Viskeraalisen rasvan estäminen ja diagnostisointi
EP2996487B1 (en) 2013-03-08 2019-12-11 Axiom Foods Inc. Rice protein supplements
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
JP6234331B2 (ja) * 2014-06-13 2017-11-22 森永乳業株式会社 統合失調症治療剤
TWI572713B (zh) * 2014-10-31 2017-03-01 豐華生物科技股份有限公司 抗肥胖之乳酸菌菌株及其於食品組成物以及醫藥組成物之應用
JP6650728B2 (ja) * 2015-03-06 2020-02-19 株式会社ファンケル ダイエット用の製剤
ES2760076T3 (es) * 2015-12-11 2020-05-13 Prec Group Limited Bifidobacterium longum para el tratamiento de obesidad y trastornos metabólicos asociados
JP6847577B2 (ja) * 2015-12-28 2021-03-24 森永乳業株式会社 ビフィドバクテリウム属細菌および／または乳酸菌の増殖促進および／または減少抑制剤
EP3442549B1 (en) * 2016-04-14 2024-03-20 International N&H Denmark ApS Bifidobacteria for increasing lean body mass
IT201600105831A1 (it) * 2016-10-20 2018-04-20 Probiotical Spa Una composizione a base di un estratto di Irvingia gabonensis e ceppi di Bifidobatteri per la regolazione e riduzione del peso corporeo
KR101920219B1 (ko) * 2017-03-08 2018-11-20 서울대학교산학협력단 비피더스균을 포함하는 비만 예방 또는 개선용 조성물
CN110868870A (zh) 2017-05-12 2020-03-06 艾斯姆食品公司 大米产物及制备它们的系统和方法
US11833178B2 (en) 2017-08-25 2023-12-05 University College Cork—National University of Ireland, Cork Bifidobacterium longum for treating obesity and weight management
CN111212575A (zh) * 2017-10-31 2020-05-29 森永乳业株式会社 肌肉增量用组合物
US20200345051A1 (en) 2017-11-24 2020-11-05 University College Cork, National University Of Ireland, Cork A composition comprising a cohort of bacteria
WO2019199094A1 (ko) * 2018-04-11 2019-10-17 한국생명공학연구원 비만의 예방 또는 치료 효과를 가지는 신규 비피도박테리움 롱검 균주 또는 락토바실러스 람노서스 균주 및 이의 용도
CN111187734A (zh) * 2019-12-25 2020-05-22 生合生物科技（扬州）有限公司 长双歧杆菌bl986、由其制备的冻干粉及冻干粉的应用
JP7475155B2 (ja) * 2020-02-14 2024-04-26 森永乳業株式会社 持久力向上用組成物
EP4070670A1 (en) 2021-04-08 2022-10-12 University College Cork-National University of Ireland Cork Lacticaseibacillus paracasei em025-11 and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61109729A (ja) * 1984-11-05 1986-05-28 Advance Res & Dev Co Ltd コレステロ−ル低下剤
JP2687229B2 (ja) * 1988-11-11 1997-12-08 株式会社ヤクルト本社 血圧降下剤
JP4280016B2 (ja) * 2002-02-28 2009-06-17 雪印乳業株式会社 糖尿病合併症予防・改善・治療剤
JP2003252771A (ja) * 2002-03-04 2003-09-10 Snow Brand Milk Prod Co Ltd 加齢に伴う代謝異常疾患の予防・改善・治療剤
SE529185C2 (sv) * 2005-10-07 2007-05-22 Arla Foods Amba Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt
JP2007169200A (ja) * 2005-12-21 2007-07-05 Morinaga Milk Ind Co Ltd インフルエンザ感染予防のための医薬及び飲食品
PL1981516T3 (pl) * 2006-01-27 2019-03-29 Dupont Nutrition Biosciences Aps Zastosowanie mikroorganizmów probiotycznych w leczeniu i zapobieganiu otyłości i pokrewnym zaburzeniom
MY148872A (en) * 2006-02-15 2013-06-14 Nestec Sa Use of bifidobacterium longum for the prevention and treatment of inflammation
AU2007242314B2 (en) * 2006-03-31 2010-07-01 Morinaga Milk Industry Co., Ltd. Interleukin production regulator, pharmaceutical composition or food comprising the interleukin production regulator, and method for production of the interleukin production regulator
KR20080075971A (ko) * 2007-02-14 2008-08-20 (주)네오팜 프로바이오틱스 복합 제제
EP1974734A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
EP2022502A1 (en) * 2007-08-10 2009-02-11 Nestec S.A. Lactobacillus rhamnosus and weight control
UA31009U (uk) * 2007-10-18 2008-03-25 Одесская Национальная Академия Пищевых Технологий Кисломолочний напій діабетичного призначення
UA30077U (uk) * 2007-10-18 2008-02-11 Одесская Национальная Академия Пищевых Технологий Композиція для йогурту діабетичного призначення
JP2009143820A (ja) * 2007-12-12 2009-07-02 Tsujido Chemical Corp 高尿酸血症の予防または改善剤

Also Published As

Publication number Publication date
CA2775976A1 (en) 2011-04-07
SG10201406169VA (en) 2014-11-27
AU2010303020B2 (en) 2014-11-20
EP2308499A1 (en) 2011-04-13
JP5911424B2 (ja) 2016-04-27
RU2012117804A (ru) 2013-11-20
CL2012000809A1 (es) 2012-07-13
AR078485A1 (es) 2011-11-09
EP2482829A1 (en) 2012-08-08
JP2013506631A (ja) 2013-02-28
WO2011039176A1 (en) 2011-04-07
MX2012003612A (es) 2012-04-19
RU2567660C2 (ru) 2015-11-10
AU2010303020A1 (en) 2012-04-19
US20120244125A1 (en) 2012-09-27
BR112012007109A2 (pt) 2016-07-05
CN102665737A (zh) 2012-09-12

Similar Documents

Publication Publication Date Title
IN2012DN02463A (xx)
TN2011000673A1 (en) Bace inhibitors
MX2011008398A (es) Lactobacillus helveticus cncm i-4095 y el control del peso.
MX350234B (es) Compuestos de enlace especificos de bacterias gram-positivas.
IN2012DN01638A (xx)
MY179933A (en) Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use thereof
MX355543B (es) Macrociclos peptidomiméticos.
EP2464724A4 (en) COMPOSITIONS AND METHODS FOR IMPLANTATION OF TREATED ADIPOSE TISSUE AND TREATED ADIPOSE TISSUE PRODUCTS
MX339878B (es) Nuevas formas solidas de clorhidrato de bendamustina.
MX2011007930A (es) Conjugados de insulina cristalina.
MY158992A (en) Forms of rifaximin and uses thereof
MY156697A (en) Modified tuberculosis antigens
MX345063B (es) Cepas probióticas para mejorar el sistema nervioso entérico.
MX340555B (es) Anticuerpos contra il-18r1 y usos de los mismos.
MX2011008400A (es) Lactobacillus rhamnosus cncm i-4096 y el control del peso.
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
MX336323B (es) Anticuerpos de anti-poliubiquitina y metodos de uso.
MX2014005765A (es) Compuestos triciclicos, composiciones que los comprenden y usos de los mismos.
EP2588121A4 (en) C5A ANALOGUES AND METHODS OF USE THEREOF
MX344303B (es) Metodos para proveer terapia de perdida de peso en pacientes con depresion mayor.
MY158310A (en) Prevention and treatment of allergic diarrhoea
IN2012DN03404A (xx)
MX2015005897A (es) Cepa de lactobacillus rhamnosus para reducir la acumulacion de grasa corporal.
MX346332B (es) Cepas probioticas para aumentar la resistencia transepitelial.
MX2011010046A (es) Derivados de diaminopteridina.